Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study

NCT06085079 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Uveitis, Posterior
Uveitis, Anterior
Uveitis, Intermediate
Panuveitis

Interventions

DRUG: Ixekizumab Prefilled Syringe

Sponsor

Massachusetts Eye Research and Surgery Institution

Collaborators

[object Object]